Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>Resources>Application Notes>This Application Note
  Application Notes
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Personalized Drug Screening for Multiple Myeloma Patients
A personalized method for testing the effectiveness of drugs that treat multiple myeloma may predict quickly and more accurately the best treatments for individual patients with the bone marrow cancer.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.
Cancer-Fighting Tomato Component Traced
The metabolic pathway associated with lycopene, the bioactive red pigment found in tomatoes, has been traced by researchers at the University of Illinois.
Batten Disease may Benefit from Gene Therapy
NIH-funded animal study suggests one-shot approach to injecting genes.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.
Molecule Proves Key to Brain Repair After Stroke
Scientists found that a molecule known as growth and differentiation factor 10 (GDF10) plays a key role in repair mechanisms following stroke.
Towards Patient-Specific Drug Screening
A new breakthrough by the 3D stem cell printing team at Heriot-Watt could pave the way to individually tailored drug testing regimes, both reducing the need for animal testing and ensuring that patients receive drugs which are most effective for their individual needs.
Antibody Targets Key Cancer Marker
University of Wisconsin-Madison researchers have created a molecular structure that attaches to a molecule on highly aggressive brain cancer and causes tumors to light up in a scanning machine.
Gut Bacteria Can Dramatically Amplify Cancer Immunotherapy
Manipulating microbes maximizes tumor immunity in mice.
Scroll Up
Scroll Down

3D cell culture: a realistic and reproducible collagen-based environment
Bookmark and Share

Tecan Group

In drug discovery and many other areas of research, cell culture using primary cells of human or animal origin is often desirable, or even essential. TAP Biosystems has developed a novel 3D cell culture technique, RAFT (Real Architecture for 3D Tissue), which uses the most abundant matrix protein in the body: type I collagen. 

This technology allows researchers to culture cell types of their choice, including primary cells, in an in vivo like environment that is essentially a hydrogel with tissue-like properties. Uniquely, the RAFT process increases the collagen concentration to physiological levels rapidly and reproducibly, while maintaining high cell viability. 

Tecan and TAP Biosystems have developed an automated process for the preparation of RAFT cell cultures, aiding mixing procedures and enhancing reproducibility while maintaining excellent cell viability and reliability. Implementation on the Freedom EVO system, with its modular automation capabilities, increases experimental versatility and analytical flexibility. 

This application note presents cell viability and proliferation data for primary neonatal human dermal fibroblasts (Life Technologies) obtained over an 11-day culture period after seeding.

Further Information

Related Content

Joining the Digital Age
TES Pharma has recently purchased an HP D300 Digital Dispenser, and is now reaping the benefits of direct titration with improved assay reproducibility and more time to perform exploratory research.
Thursday, February 21, 2013
Tecan and Pion Expand Collaboration to Develop Automated Drug Screening Solutions
The new automated application provides scalability from an entry-level manual system to a fully automated system with medium or high throughput.
Thursday, July 16, 2009
A perfect fit for the Freedom EVO® 75 in forensic toxicology
Immunalysis Corporation tailors the Tecan Freedom EVO 75 liquid handing workstation as the platform of choice to provide customized semi and fully automated drugs of abuse screening solutions.
Friday, March 14, 2008

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos